UNCY - Unicycive Therapeutics, Inc.
0.55
-0.072 -13.109%
Share volume: 1,800,352
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$0.62
-0.07
-0.12%
Summary score
40%
Profitability
33%
Dept financing
49%
Liquidity
75%
Performance
37%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
102.63%
Return on assets
-44.65%
Return on sales
-603.27%
Return on invested capital
106.28%
Total debt ratio
71.45%
Debt ratio change over timeo
0.62%
Current Ratio
2.81%
Quick Ratio
2.85%
Cash Position Ratio
2.39%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-4.33%
Return on assets
-29.14%
Return on sales
0%
Return on invested capital
34.1%
Total debt ratio
90.81%
Debt ratio change over timeo
1.79%
Current Ratio
1.74%
Quick Ratio
1.13%
Cash Position Ratio
1.48%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-40.11%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
146.69%
Debt ratio change over time
2.54%
Current Ratio
1.71%
Quick Ratio
0%
Cash Position Ratio
1.62%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
50.22%
Return on assets
-173.8%
Return on sales
-423.99%
Return on invested capital
-5.57%
Total debt ratio
61.88%
Debt ratio change over time
0.62%
Current Ratio
1.48%
Quick Ratio
1.24%
Cash Position Ratio
1.04%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | UNCY | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 102.63% | 18.86% | 8.19% | 17.34% |
| Return on assets | -44.65% | 4.09% | 3.09% | 8.21% |
| Return on sales | -603.27% | 27.43% | 25.26% | 41.18% |
| Return on invested capital | 106.28% | 8.62% | 7.99% | -219.55% |
| Profitability | 50% | 36% | 29% | 54% |
| Total debt ratio | 71.45% | 82.89% | 60.02% | 55.88% |
| Debt ratio change over time | 0.62% | -9.8% | -36.79% | 0% |
| Dept financing | 47% | 25% | 18% | 17% |
| Current Ratio | 1.74% | 1.12% | 1.16% | 0% |
| Quick Ratio | 1.13% | 0.86% | 0.92% | 0% |
| Cash Position Ratio | 1.48% | 0.12% | 0.51% | 0% |
| Liquididy | 75% | 21% | 27% | 21% |
| Short-term ratios | UNCY | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -4.33% | 7.71% | 21.69% | 0% |
| Return on assets | -29.14% | 4.46% | 2.98% | 0% |
| Return on sales | 0% | 29.24% | 25.4% | 0% |
| Return on invested capital | 34.1% | 5.83% | 22.48% | 0% |
| Profitability | 25% | 63% | 80% | 0% |
| Total debt ratio | 90.81% | 80.89% | 59.04% | 0% |
| Debt ratio change over time | 1.79% | -57.9% | -209.85% | 0% |
| Dept financing | 50% | 22% | 16% | 0% |
| Current Ratio | 1.74% | 1.12% | 1.16% | 0% |
| Quick Ratio | 1.13% | 0.86% | 0.92% | 0% |
| Cash Position Ratio | 1.48% | 0.12% | 0.51% | 0% |
| Liquididy | 75% | 37% | 46% | 0% |
